MedPath

Peru Longitudinal Study

Not Applicable
Terminated
Conditions
Cardiovascular Diseases
Diabetes Mellitus
Hypertension
Dyslipidemias
Overweight and Obesity
Interventions
Behavioral: Lifestyle Modification
Registration Number
NCT03742219
Lead Sponsor
Ohio University
Brief Summary

The purpose of this study is to evaluate the change in disease prevalence over time in impoverished urban communities in Lima, Peru.

Detailed Description

The aim is to track the changes in disease prevalence of people living in impoverished urban communities in Lima over the next 10 years.

Based on data collected in prior years and in an ongoing manner, Ohio University Global Health teams will be introducing interventions focused to positively impact disease states and trends in this population.

The current focus is on chronic lifestyle related diseases and their precursors: cardiovascular disease, hypertension, dyslipidemia, diabetes, and overweight / obesity.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
861
Inclusion Criteria
  • minors age 12-17 presenting to the free community clinic, with a responsible adult who can give consent; minors will give assent.
  • consenting adults of any age who present to the clinic.
Exclusion Criteria
  • adults who are unable to give consent.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Lifestyle InterventionLifestyle ModificationImpoverished communities in Lima, Peru will be offered free medical clinics. Four communities have been chosen initially for focus over the following 10 years. These communities will be made aware of their risk for chronic lifestyle related diseases. In conjunction with the communities, specific interventions focused on a plant-based diet, physical activity, stress management and control of unhealthy habits will be devised.
Primary Outcome Measures
NameTimeMethod
High density lipoprotein cholesterolperiodically over 10 years

measured in percent via fingerstick capillary blood and portable analyzer

Weightyearly for 10 years

weight in kilograms will be utilized to determine body mass index

Systolic blood pressureyearly for 10 years

measured with a manual sphygmomanometer in millimeters of mercury

glycosylated hemoglobinperiodically over 10 years

measured in percent via fingerstick capillary blood and portable analyzer

Total cholesterolperiodically over 10 years

measured in percent via fingerstick capillary blood and portable analyzer

Diastolic Blood Pressureyearly for 10 years

measured with a manual sphygmomanometer in millimeters of mercury

Low-density lipoprotein cholesterolperiodically over 10 years

measured in percent via fingerstick capillary blood and portable analyzer

Triglyceridesperiodically over 10 years

measured in percent via fingerstick capillary blood and portable analyzer

Secondary Outcome Measures
NameTimeMethod
Household hunger scaleyearly for 10 years

validated survey to measure food insecurity

Patient Health Questionnaire - 4 (PHQ-4)yearly for 10 years

used to evaluate depression and anxiety

Perceived Stress Scaleyearly for 10 years

validated survey to evaluate level of stress

Exercise vital signyearly for 10 years

the minutes of exercise during the last week

Herth Hope Indexyearly for 10 years

validated survey utilized to evaluate level of hope for the future

24 hour dietary recallyearly for 10 years

report of all foods consumed in the last 24 hours, which will be utilized to determine the nutritional value of dietary intake

Trial Locations

Locations (1)

Ohio University

🇺🇸

Athens, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath